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Randomized controlled trials (RCTs)
are considered the ‘‘gold standard’’ study
design in health research. The random
allocation of participants to intervention
and control groups minimizes systematic
differences between groups and the biases
that can result. RCTs have become
standard practice in the evaluation of
medical and pharmaceutical treatments.
In contrast, environmental (and occupa-
tional) health research has relied primarily
on observational methods; randomized
studies to test the effect of an environ-
mental exposure or the efficacy of an
intervention to prevent or reduce exposure
are rare.
A search of PubMed articles in journals
focused on medicine, environmental
health, and clinical trials revealed that
only 0.6% of environmental health publi-
cations since 2000 were RCTs of an
intervention to reduce exposure (S1 Text).
RCTs contribute a larger portion of the
environmental health publications in top-
ranked medical journals (4%) than in
environmental health journals (0.4%)—
an unsurprising result given the emphasis
on clinical trials in medical research and
the widespread perception that observa-
tional studies are inferior. The RCTs
published to date have focused primarily
on allergens, drinking water, household air
pollution (HAP) from solid cooking fuels,
lead, environmental tobacco smoke, and
pesticides.
RCTs should be used more frequently
to study environmental hazards (see Box
1). In calling for more randomized studies
of interventions our objective is not to offer
yet another admonishment of observation-
al epidemiology [1–3]. The contributions
that observational research has made to
our understanding of environmental risks
and the development of environmental
health policy are impressive. Notable
examples include ambient air pollution
[4], lead [5], radon [6], arsenic [7], and
asbestos [8], all of which are now known
to cause substantial morbidity and mor-
tality, and have policies in place to
mitigate their health risks, based almost
entirely on observational evidence [9].
Well-designed and carefully conducted
randomized trials would complement this
strong tradition of observational research.
The fundamental advantages of random-
ized designs, such as minimization of
confounding bias, are described elsewhere
and need not be reiterated here. Instead,
we aim to highlight how RCTs might be
beneficial to environmental health re-
search and describe some considerations
for the appropriate use of RCTs to assess
environmental risks and the efficacy of
interventions.
Why Are More RCTs Needed?
Interventions to reduce or eliminate
environmental exposures are urgently
needed; environmental risks account
for 13%–37% of the disease burden
(quantified by disability-adjusted life years)
in individual countries [10,11]. The
individual-level health risks of environ-
mental exposures are often modest, but
the population-level impacts are substan-
tial because exposures are highly prevalent
or ubiquitous and contribute to common
diseases and disabilities [9]. Environmen-
tal exposures affect health in both high-
income countries and low- and middle-
income countries (LMIC), although the
relative importance of specific risk factors
and the magnitude of the risks vary with
economic development [12].
RCTs can generally provide more
definitive evidence of causality than ob-
servational studies. As a result, greater use
of RCTs in environmental health would
help to emphasize prevention over treat-
ment by altering the perception that
environmental risks are evaluated less
rigorously than medical and pharmaceuti-
cal interventions. As previously noted in
the context of HAP, the perception that
environmental interventions are evaluated
with insufficient rigor has important im-
plications for the allocation of limited
resources:
Essays are opinion pieces on a topic of broad
interest to a general medical audience.
Citation: Allen RW, Barn PK, Lanphear BP (2015) Randomized Controlled Trials in Environmental Health
Research: Unethical or Underutilized? PLoS Med 12(1): e1001775. doi:10.1371/journal.pmed.1001775
Published January 6, 2015
Copyright:  2015 Allen et al. This is an open-access article distributed under the terms of the Creative
Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium,
provided the original author and source are credited.
Funding: No funding was received for this work.
Competing Interests: RWA has received grant and/or contract support from the Canadian Institutes of
Health Research, Health Canada, the British Columbia (BC) Ministry of Environment, the BC Lung Association,
and the Allergy, Genes, and Environment Network. He has received honoraria for committee participation, peer
review, etc. from the BC Lung Association, the Health Effects Institute, and the US EPA. He has received travel
funds from the Universidad del Valle (Colombia), the Montreal Department of Public Health, and the Allergy,
Genes, and Environment Network. PKB has received research funding, scholarships, and awards from the Air &
Waste Management Association, British Columbia Environmental and Occupational Health Research Network,
Canadian Institutes of Health Research, Canadian International Development Agency, Fraser Basin Council,
Provincial Health Services Authority, Simon Fraser University, and the Vancouver Foundation. BPL has served as
an expert witness and as a consultant to the California Attorney General’s Office and in a California public
nuisance case against the paint and pigment industry, but he has not personally received any compensation
for these services. BL has also served as a paid consultant on a US Environmental Protection Agency research
study and the California Department of Toxic Substances. He has received NIH, US EPA and Canadian Institutes
for Health Research grant support.
Abbreviations: HAP, household air pollution; HEPA, high efficiency particulate air; LMIC, low- and middle-
income countries; PM, particulate matter; RCT, randomized controlled trial; TSC, Total Sanitation Campaign;
UGAAR, Ulaanbaatar Gestation and Air Pollution Research.
* Email: allenr@sfu.ca
Provenance: Commissioned; externally peer reviewed
PLOS Medicine | www.plosmedicine.org 1 January 2015 | Volume 12 | Issue 1 | e1001775
‘‘[Randomized] studies would go a
long way in making the argument
about causality to health ministries
and international agencies that sup-
port them, who usually have very
limited resources to deal with a
number of large health problems.
They have the results of rigorous
studies focused on other means of
dealing with these same diseases…
At present, as the effectiveness and
cost of such measures has been
much better established, [HAP]
interventions garner little attraction.
On the other hand, the currently
available interventions are clearly
imperfect and will not serve to
entirely control the diseases’’ [13].
Environmental interventions are cost-
effective investments [14]. For example,
each dollar invested to control lead
hazards in the United States would result
in benefits of $17–$221 [15]. By 2020 the
cumulative benefits of the 1990 US Clean
Air Act Amendments are projected to
outweigh costs by a ratio of 30 to 1 [16].
Globally, the annual economic benefit of
halving the population without access to
improved cooking stoves is estimated at
$105 billion compared to a net cost of $34
billion [17].
Well-designed RCTs can also identify
inefficacious or even harmful interven-
tions. For example, several studies report-
ed that residential lead abatement in-
creased children’s blood lead levels,
which led to post-abatement lead-dust
standards to protect children from the
short-term risks of lead released during
abatement or renovation [18,19]. Even if
they do not increase health risks, non-
efficacious interventions can be a waste of
scarce resources and provide a false sense
of safety [20,21]. In the absence of
evidence, individuals will often turn to
unproven solutions—like surgical masks,
which are commonplace in many cities
with poor air quality but do little to reduce
health risks from air pollution [22].
Individuals Versus Populations
Most environmental health RCTs con-
ducted to date have evaluated interven-
tions on individuals or households, but
RCTs may also be appropriate for evalu-
ating interventions implemented at the
community level. For example, Patil and
colleagues conducted an RCT in 80
villages to evaluate the effect of India’s
Total Sanitation Campaign (TSC) on the
availability of improved sanitation, open
defecation behaviors, water quality, and
childhood diarrheal and gastrointestinal
illnesses [23]. Villages randomized to the
intervention group received the TSC,
while control group villages received the
TSC after the trial was completed. In
other situations, it may be infeasible (or
unethical) to randomize communities to
the intervention, and ‘‘natural experi-
ments’’ evaluating temporal changes in
exposure and health may be a more
appropriate design [24–27].
From a public health perspective, pro-
grams that reduce pollution emissions and
exposure among large populations will
always be preferable to interventions that
attempt to reduce exposure at the individ-
ual or household level after the pollutants
have been widely distributed. Neverthe-
less, RCT evaluations of interventions at
the individual or household level can have
tremendous value. Robust evidence that
exposure reductions lead to improvements
in health—even at the individual level—
may make the argument for policy inter-
ventions at the population level more
persuasive. The simplicity of the RCT
design also makes it relatively easy to
communicate results to non-researchers.
Thus, even if the intervention under study
is not feasible on a large scale, the
information generated on exposure–health
relationships may have relevance to pop-
ulation health and policy. Using RCTs to
demonstrate efficacy for individual- or
household-level interventions can also be
valuable if emissions or production cannot
be directly controlled. For example, wild-
fire smoke and radon are naturally occur-
ring pollutants for which risk management
involves exposure reduction primarily at
the household level [28,29].
RCTs are ideal for demonstrating
efficacy (performance of the intervention
under optimal conditions) but are gener-
ally inadequate for evaluating effectiveness
(performance of the intervention under
‘‘real world’’ conditions) [30]. In clinical
trials external validity is often limited
because the demographics and health of
study populations differ from their target
populations [31]. External validity for
RCTs in environmental health can be
further influenced by the complexity of
‘‘scaling-up’’ interventions to a larger
population [32]. An intervention’s impact
on health at the population level depends
on efficacy, but also on user compliance,
delivery, programming, and government
policy [33]. Thus, RCTs generally repre-
sent the first step in developing an effective
environmental intervention program.
Summary Points
N Efficacious environmental interventions are needed because environmental
risks account for a large fraction of the global disease burden.
N Randomized controlled trials have not been widely embraced by environmental
health researchers and comprise less than 1% of research publications in the
field.
N Additional randomized controlled trials in environmental health would
complement a strong tradition of observational research by creating new
knowledge on exposure–health relationships, providing more definitive
evidence of causality, identifying efficacious interventions to reduce or
eliminate hazards, and countering the perception that environmental risks
are evaluated with inadequate rigor.
N Ethical issues—including clinical equipoise, the distribution of benefits and
risks, and the relevance of the intervention and health outcome to the study
population—must be carefully considered before conducting a randomized
controlled trial of an environmental intervention.
Box 1. Randomized Controlled Trials
The RCT is a powerful research design that may have applicability to a wide range
of risk factors in the physical, built, and social environments. RCTs may be
appropriate and should be considered when the following criteria are met: (1)
there is uncertainty about which (if any) intervention is most effective (i.e., clinical
equipoise) or the gold standard intervention is not being implemented; (2) the
intervention to be studied is feasible and affordable to the local community; (3)
the intervention addresses a health risk affecting the local community; and (4) the
health outcome and the timescale of the exposure–response relationship can
feasibly be studied using the RCT design.
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Some have suggested that the relatively
small study populations in RCTs are only
capable of detecting ‘‘large’’ health effects
and that RCTs are therefore not useful in
public (or environmental) health research
[34]. However, this is not necessarily the
case because the small populations in
RCTs are offset by three advantages. First,
the smaller populations in RCTs often
allow for refined, individual-level exposure
assessment using environmental measure-
ments and/or exposure biomarkers that is
often not possible in larger observational
studies. A reduction of non-differential
exposure misclassification can dramatical-
ly enhance our ability to detect relation-
ships with health outcomes. Second, the
ability to detect relationships between
exposure and health depends, in part, on
the size of the exposure gradient in the
population. Ironically, it is the ubiquity of
many environmental exposures that makes
their relationship with health difficult to
uncover because ‘‘the hardest cause to
identify is one that is universally present,
for then it has no influence on the
distribution of disease’’ [35]. RCTs can
substantially increase the exposure gradi-
ent in the study population—and thus our
ability to detect associations with health—
by reducing exposure in the intervention
group. Finally, environmental health re-
searchers often struggle to identify the
causative agent because many exposures
share common sources and are therefore
correlated. By reducing one specific expo-
sure we can decrease its correlations with
other exposures and more clearly identify
the key agent(s) impacting health. For
example, high efficiency particulate air
(HEPA) filters reduce particulate matter
(PM) air pollution concentrations indoors,
but they have little effect on gaseous
pollutants [36]. Thus, studies demonstrat-
ing health benefits from HEPA filtration
provide evidence that PM plays an
important role [36–38].
Ethical Considerations
RCTs raise important ethical questions,
and while a comprehensive review of
ethical considerations is beyond the scope
of this essay, some issues with relevance to
environmental health research should be
mentioned. The fundamental question
with all RCTs is whether it is ethical to
provide a potentially beneficial treatment
or intervention to some participants but
not to others [39]. It is widely accepted
that RCTs are only ethical in situations of
clinical equipoise—genuine uncertainty
among the community of experts about
which (if any) intervention is most effective
[40]. No participant in a randomized trial
should receive a placebo or an inferior
intervention if an efficacious intervention
has been identified [41]. It is often
assumed that participants assigned to the
intervention group in an RCT will benefit,
but if equipoise exists the intervention is as
likely to be non-efficacious as it is to be
beneficial [20,42], and in some cases the
intervention may unintentionally increase
exposure [19,43].
Research participants should receive a
fair share of the benefits from the research
and the benefits to participants and society
should be proportional to or outweigh the
risks [39,44]. In addition, the research
must address a health problem of rele-
vance to the population under study and
the population should be selected based on
the research objectives, not the popula-
tion’s vulnerability [45]. These consider-
ations also have applicability to RCTs
conducted in LMIC. While many clinical
trials are now conducted in LMIC for
financial reasons [46], many randomized
studies of environmental interventions
focus on LMIC because that is where
the public health burden of many envi-
ronmental risks is greatest and where the
risks are often concentrated at the
household level [9,12]. These studies are
ethical only if the intervention being
tested is feasible and affordable in the
local context and addresses a health risk
of relevance to the population under
study. Finally, researchers should clearly
communicate that the study will not
intentionally increase exposure to envi-
ronmental hazards [47].
Other Considerations
An important consideration for the
RCT design is the timescale of the
exposure–health relationship. It may be
prohibitively expensive and difficult to
mount RCTs for studying diseases with
long latency periods, such as cancer or
cardiovascular disease, but the RCT may
be useful for testing the efficacy of
interventions to reduce exposure to known
carcinogens or cardiovascular risks (e.g.
arsenic, lead) or for studying intermediate
biological processes (e.g., systemic inflam-
mation, endothelial dysfunction). The
RCT design should also be considered in
studies of acute or sub-chronic health
effects and/or in situations with a well-
defined exposure period of interest (e.g.,
pregnancy).
A key difference between clinical trials
and RCTs of environmental interventions
is that in the latter it is often difficult to
blind participants and research personnel
to intervention status. This may lead to
biased effect estimates, particularly when
investigating subjectively assessed health
outcomes [48]. For example, unblinded
studies of water treatment interventions in
LMIC suggest that interventions produce
substantial reductions in risk of diarrhea,
while a smaller number of blinded studies
have not found comparable benefits [49].
Even if participants cannot be blinded
researchers should strive to rely on
‘‘hard,’’ objective outcomes, and person-
nel responsible for outcome assessment
should be blinded (i.e., single blind).
Although many of the environmental
health RCTs conducted to date have
studied relatively simple interventions
focused on a single environmental hazard,
some have evaluated multifactorial inter-
ventions aimed at multiple exposures
[50,51]. Other fields have applied the
RCT design more frequently and ambi-
tiously. For example, the ‘‘Moving to
Opportunities’’ study randomized over
4,000 families in high-poverty areas of
several US cities into one of two housing
mobility intervention groups or a control
group and evaluated relationships with a
range of outcomes [52–56]. The MIT
Poverty Action Lab is using RCTs to
address a wide range of questions in
international development [57].
Our ongoing Ulaanbaatar Gestation
and Air Pollution Research (UGAAR)
study provides a useful example of a
RCT in environmental health. Several
large, well-conducted observational studies
have suggested a link between ambient air
pollution and impaired fetal growth
[58,59], but concerns about confounding
and exposure misclassification remain
[60]. We are randomizing approximately
500 pregnant women into either a HEPA
filter intervention group or a control group
(no filter); women in the intervention
group will have HEPA filters operating
in their home from enrollment until the
child’s birth. Ulaanbaatar, Mongolia is an
ideal location to test the efficacy of this
intervention because it has extraordinarily
high air pollution concentrations [61] that
are likely to remain elevated for decades
even under the most optimistic scenarios
[62,63]. This situation is not unique—
nearly 90% of the world’s population
breathes air pollution that exceeds WHO
guidelines, and concentrations are increas-
ing in much of the world [64] —so there is
value in identifying efficacious interven-
tions that can reduce health risks in the
near term until regulations, technology,
and economic development can reduce
air pollution to acceptable levels. The
randomized design should minimize
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confounding, and the high pollution
concentrations and large exposure gradi-
ents created by the intervention provide
statistical power among a relatively small
study population on which detailed,
household-level exposure assessment can
be conducted. HEPA filters are a feasible
and affordable intervention, and impaired
fetal growth is a relevant outcome in this
population.
Conclusions
Randomized controlled trials are stan-
dard practice in clinical and pharmaceu-
tical research but have not been embraced
by environmental health researchers.
Greater use of the RCT design would
complement the tremendous contributions
made by other methods—including both
observational epidemiology and toxicolo-
gy—to our understanding of environmen-
tal risks and the development of environ-
mental health policy. Researchers,
academic institutions, and funding agen-
cies have a role to play in expanding the
use of RCTs in environmental health
research. Researchers should think crea-
tively about potential interventions and
consider the RCT as a possible study
design to test their specific research
question. Funding agencies should allocate
money specifically for randomized studies
of environmental interventions. In addi-
tion to its scientific advantages, this would
provide the additional benefit of encour-
aging research that aims not only to
identify problems but also to identify
possible solutions. Ethical issues must be
considered carefully, and while institution-
al ethics approval is necessary, it is not
sufficient to ensure that the research is
conducted ethically. The RCT design has
important limitations and is not applicable
to all research questions, so observational
studies will, and should, remain the
workhorse in environmental health
research. Nevertheless, RCTs can help
advance the field of environmental health
by creating new knowledge of exposure–
health relationships, providing more de-
finitive evidence of causality, identifying
efficacious interventions to reduce or
eliminate exposure and health risks, and
countering the perception that environ-
mental risks are evaluated with inadequate
rigor.
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